Results 131 to 140 of about 10,163 (201)

Temporal dynamics of IgG-mediated immunometabolic dysfunction: from acute obesity to chronic aging. [PDF]

Front Immunol
Kim S, Kim J, Lee HL, Kim MS.
europepmc   +1 more source

Biomimetic nanovesicles decorated with chemotactic and target membrane proteins for lupus nephritis treatment. [PDF]

J Nanobiotechnology
Gan J, Huang D, Liu R, Zhao Y, Sun L.
europepmc   +1 more source

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications. [PDF]

Biomedicines
Mansour GK, Alangari L, Khosyfan L, Alhammad R, Hajjar AW.   +4 more
europepmc   +1 more source

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study. [PDF]

J Neurol
Oeztuerk M, Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Rehmann R, Arat E, Menskes CB, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meisel A, Meuth SG, Ruck T.   +26 more
europepmc   +1 more source

FcRn inhibitors for myasthenia gravis

Cochrane Database of Systematic Reviews
Laura M White, Fiona J Clay, Anne-Marie Forbes, Ryan Yann Shern Keh, James B Lilleker, Jennifer Spillane, Karen Storms, Katherine C Dodd, Jon Sussman   +8 more
openaire   +2 more sources

Immunotherapy in Chronic Inflammatory Demyelinating Polyneuropathy and the Emerging Role of Efgartigimod. [PDF]

J Clin Neurol
Park JS, Kang M.
europepmc   +1 more source

Immunoglobulin G Fc engineering for localized therapy: Eliminating neonatal Fc receptor interactions and ensuring purification using protein A. [PDF]

Protein Sci
Kato A, Toshima A, Takekawa G, Miyagi H, Kubota A, Hori S, Uemura Y, Niwa R.   +7 more
europepmc   +1 more source

Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG Modification. [PDF]

Chemistry
Kawakami H, Rafique A, Tsuda S, Nagashima A, Nohara Y, Dozono N, Sakamoto K, Masuda S, Kiyoshi M, Shibata H, Ishii-Watabe A, Yoshiya T, Ito Y.   +12 more
europepmc   +1 more source

Dulaglutide and pregnancy: a comprehensive safety assessment using the <i>ex vivo</i> placenta perfusion and <i>in vitro</i> models. [PDF]

Front Pharmacol
Kuoni S, Caviglia S, Dolder A, Gawinecka J, Ochsenbein-Kölble N, Simões-Wüst AP.   +5 more
europepmc   +1 more source

Progress in the Treatment of Refractory Myasthenia Gravis. [PDF]

Rev Neurol
Liu D, Mao J, Song J, Wang M.
europepmc   +1 more source